BG

Bollard Group Portfolio holdings

AUM $3.81B
1-Year Est. Return 16.6%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+16.6%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$4.04B
AUM Growth
-$176M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
298
New
Increased
Reduced
Closed

Top Buys

1
+$4.87M
2
+$4.86M
3
+$3.88M
4
MSFT icon
Microsoft
MSFT
+$3.87M
5
EPD icon
Enterprise Products Partners
EPD
+$3.66M

Top Sells

1
+$35.8M
2
+$32.9M
3
+$18.4M
4
BNTX icon
BioNTech
BNTX
+$2.75M
5
ENTG icon
Entegris
ENTG
+$1.85M

Sector Composition

1 Healthcare 53.91%
2 Technology 7.72%
3 Energy 7.68%
4 Utilities 5.26%
5 Consumer Discretionary 5.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WHR icon
276
Whirlpool
WHR
$4.34B
– –
-47
DOCU
277
DocuSign
DOCU
$9.03B
– –
-9,053
DT icon
278
Dynatrace
DT
$10.7B
– –
-16,566
ENTG icon
279
Entegris
ENTG
$20.1B
– –
-22,947
ESTC icon
280
Elastic
ESTC
$5.49B
– –
-16,924
FLYW icon
281
Flywire
FLYW
$1.5B
– –
-25,609
FTV icon
282
Fortive
FTV
$18.6B
$0 ﹤0.01%
3
INSM icon
283
Insmed
INSM
$31.8B
– –
-17,191
IOVA icon
284
Iovance Biotherapeutics
IOVA
$1.53B
– –
-10,700
IRON icon
285
Disc Medicine
IRON
$2.51B
– –
-30,635
KVUE icon
286
Kenvue
KVUE
$36.6B
$0 ﹤0.01%
15
MZTI
287
The Marzetti Company
MZTI
$4.51B
– –
0
NICE icon
288
Nice
NICE
$7.18B
– –
-4,974
NOG icon
289
Northern Oil and Gas
NOG
$2.69B
– –
-589
NRIX icon
290
Nurix Therapeutics
NRIX
$1.64B
– –
-122,782
OLO
291
DELISTED
Olo Inc
OLO
– –
-9,510
OMCL icon
292
Omnicell
OMCL
$1.84B
$0 ﹤0.01%
1
PD icon
293
PagerDuty
PD
$648M
– –
-94,658
RVTY icon
294
Revvity
RVTY
$11B
– –
-18,439
SLDB icon
295
Solid Biosciences
SLDB
$484M
– –
-361,660
TENB icon
296
Tenable Holdings
TENB
$2.28B
– –
-34,277
TYL icon
297
Tyler Technologies
TYL
$15.3B
– –
-1,462
VERA icon
298
Vera Therapeutics
VERA
$2.9B
– –
-64,042
8 9 10 11
12